drugset / Trial / NCT06660173
A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)
RandomizedParallel-groupDouble-blindTreatment
Summary
The main purpose of this study is to assess the dose-response relationship of maridebart cafraglutide on glucose control compared with placebo.
Timeline
- Start
- 2024-11-07
- Primary completion
- 2025-10-06
- Completion
- 2026-11-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Maridebart Cafraglutide | Unknown | — | Subcutaneous |